Cover Image
Market Research Report

Diagnostic Testing of STDs Market, By Test Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published by Coherent Market Insights Product code 948356
Published Content info 155 Pages
Delivery time: 2-3 business days
Price
Back to Top
Diagnostic Testing of STDs Market, By Test Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Published: June 16, 2020 Content info: 155 Pages
Description

Title:
Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Diagnostic Testing of STDs are used for identification and diagnosis of sexually transmitted diseases. These diseases are transmitted through person-to-person sexual contact. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. Moreover, increasing incidence of STDs in developing and developed economies along with increasing awareness is also expected to drive the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Diagnostic Testing of STDs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Diagnostic Testing of STDs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Diagnostic Testing of STDs market

Detailed Segmentation:

  • Global Diagnostic Testing of STDs Market, By Test Type:
    • Chlamydia
    • Gonorrhea
    • Syphilis
    • HIV
    • HPV+pap smear
    • HSV
    • Chancroid
  • Global Diagnostic Testing of STDs Market, By Region:
    • North America
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • Vela Diagnostics USA Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Roche Holdings AG
    • Alere, Inc.
    • Becton Dickinson & Company
    • bioMerieux
    • Danaher Corporation (Beckman Coulter)
    • Hologic, Inc.
    • binx health
    • Chembio Diagnostics
    • Pinpoint Science Inc.
    • bioLytical Laboratories

"*" marked represents similar segmentation in other categories in the respective section..

Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Diagnostic Testing of STDs Market, By Test Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Chlamydia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gonorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Syphilis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HPV+pap smear
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HSV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chancroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Diagnostic Testing of STDs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • Vela Diagnostics USA Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Roche Holdings AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Alere, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton Dickinson & Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • bioMerieux
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Danaher Corporation (Beckman Coulter)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hologic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • binx health
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chembio Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pinpoint Science Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • bioLytical Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top